1. Home
  2. APDN vs ENTO Comparison

APDN vs ENTO Comparison

Compare APDN & ENTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APDN
  • ENTO
  • Stock Information
  • Founded
  • APDN 1983
  • ENTO 2014
  • Country
  • APDN United States
  • ENTO United States
  • Employees
  • APDN N/A
  • ENTO 2
  • Industry
  • APDN Other Consumer Services
  • ENTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • APDN Consumer Discretionary
  • ENTO Health Care
  • Exchange
  • APDN Nasdaq
  • ENTO Nasdaq
  • Market Cap
  • APDN 2.0M
  • ENTO 1.7M
  • IPO Year
  • APDN N/A
  • ENTO 2016
  • Fundamental
  • Price
  • APDN $0.84
  • ENTO $0.36
  • Analyst Decision
  • APDN Strong Buy
  • ENTO
  • Analyst Count
  • APDN 1
  • ENTO 0
  • Target Price
  • APDN $75.00
  • ENTO N/A
  • AVG Volume (30 Days)
  • APDN 1.5M
  • ENTO 1.4M
  • Earning Date
  • APDN 05-09-2025
  • ENTO 05-20-2025
  • Dividend Yield
  • APDN N/A
  • ENTO N/A
  • EPS Growth
  • APDN N/A
  • ENTO N/A
  • EPS
  • APDN N/A
  • ENTO N/A
  • Revenue
  • APDN $3,736,873.00
  • ENTO N/A
  • Revenue This Year
  • APDN $57.08
  • ENTO N/A
  • Revenue Next Year
  • APDN $40.00
  • ENTO N/A
  • P/E Ratio
  • APDN N/A
  • ENTO N/A
  • Revenue Growth
  • APDN N/A
  • ENTO N/A
  • 52 Week Low
  • APDN $0.72
  • ENTO $0.19
  • 52 Week High
  • APDN $246.00
  • ENTO $3.24
  • Technical
  • Relative Strength Index (RSI)
  • APDN 22.16
  • ENTO 38.33
  • Support Level
  • APDN $0.82
  • ENTO $0.38
  • Resistance Level
  • APDN $0.95
  • ENTO $0.39
  • Average True Range (ATR)
  • APDN 0.15
  • ENTO 0.04
  • MACD
  • APDN 0.17
  • ENTO -0.00
  • Stochastic Oscillator
  • APDN 13.34
  • ENTO 18.24

About APDN Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

About ENTO Entero Therapeutics Inc. Common Stock

Entero Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases. The company's programs address unmet needs in GI health and include: latiglutenase, a Phase 3-ready, potentially first-in-class, targeted, oral biotherapeutic for celiac disease; capeserod, a selective 5-HT4 receptor partial agonist for indications including gastroparesis; and adrulipase, a recombinant lipase enzyme designed to enable the digestion of fats and other nutrients in cystic fibrosis and chronic pancreatitis patients with exocrine pancreatic insufficiency.

Share on Social Networks: